Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

34.70
+1.454.36%
Volume:178.48K
Turnover:6.07M
Market Cap:140.71M
PE:- -
High:34.84
Open:32.91
Low:32.73
Close:33.25
52wk High:42.39
52wk Low:13.60
Shares:4.05M
Float Shares:4.05M
Volume Ratio:0.83
T/O Rate:4.40%
Dividend:15.23
Dividend Rate:43.90%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
2 hours ago

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Yesterday

Moderna to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Yesterday

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

TradingKey
·
Yesterday

Cboe data suggests bullish flow in Moderna with shares up 0.71%

TIPRANKS
·
Yesterday

Moderna Stock (MRNA) Was the Best Performer in August

TIPRANKS
·
Yesterday

New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform

Stock News
·
Aug 31

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Aug 31

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Deep News
·
Aug 30

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TIPRANKS
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

US Stocks Weekly: AI Refuel

Reuters
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

Top Calls On Wall Street: Nvidia, SpaceX, Moderna, TeraWulf , Amazon,Marvell, and More

Tiger Newspress
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28